(Q54299156)

27 May 2018

title

Impact of adherence to disease-modifying therapies on clinical and economic outcomes among patients with multiple sclerosis. (English)

1 reference

27 May 2018

0 references

Hiangkiat Tan

1

1 reference

27 May 2018

Qian Cai

2

1 reference

27 May 2018

Sonalee Agarwal

3

1 reference

27 May 2018

Judith J Stephenson

4

1 reference

27 May 2018

Siddhesh Kamat

5

1 reference

27 May 2018

language of work or name

English

0 references

publication date

6 December 2010

1 reference

27 May 2018

published in

Advances in Therapy

1 reference

27 May 2018

volume

28

1 reference

27 May 2018

issue

1

1 reference

27 May 2018

page(s)

51-61

1 reference

27 May 2018

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

1 reference

Epidemiology and natural history of multiple sclerosis: new insights

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Disease modifying therapies in multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and the MS Council for Clinical Practice Guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Effect of relapses on development of residual deficit in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

21 January 2018

Adherence to Medication

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Long-term interferon-beta treatment for multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Optimizing the benefit of multiple sclerosis therapy: the importance of treatment adherence

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Interrupted therapy: stopping and switching of the beta-interferons prescribed for MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Shifting the paradigm toward earlier treatment of multiple sclerosis with interferon beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Early intervention in multiple sclerosis : better outcomes for patients and society?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Methods for evaluation of medication adherence and persistence using automated databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Medication compliance and persistence: terminology and definitions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Glatiramer acetate versus interferon beta-1a for subcutaneous administration: comparison of outcomes among multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Glatiramer acetate and interferon beta-1b: a study of outcomes among patients with multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Impact of adherence to interferons in the treatment of multiple sclerosis: a non-experimental, retrospective, cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Compliance, adherence, and the treatment of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Tracking health care costs: continued stability but at high rates in 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Factors that influence adherence with disease-modifying therapy in MS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

Clinical and economic impact of a specialty care management program among patients with multiple sclerosis: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12325-010-0093-7

10.1007/S12325-010-0093-7

21 January 2018

Identifiers

DOI

1 reference

27 May 2018

1 reference

27 May 2018